Stock Rating Downgrade
Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for Astrazeneca PLC (NASDAQ: AZN) weakened of late. AZN’s current Value Trend Rating is D and the prior Rating was C. Details supporting this lower rating are included in our next report.
Recent Price Action
On 1/31/25, Astrazeneca PLC (NASDAQ: AZN) stock declined slightly by -0.7%, closing at $70.76. However, this decline was accompanied by below average trading volume at 75% of normal. The stock has risen 3.1% during the last week but has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Astrazeneca has a current Value Trend Rating of D (Negative). This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. Astrazeneca has a neutral Appreciation Score of 50 but a poor Power Rating of 27, producing the Negative Value Trend Rating.
Be the first to comment